EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ UMN Pharma
@ FUJICOPIAN
@ Kurogane Kosakusho
@ マルマン
@ NIPPON ICHI SOFTWARE
@ Medrx
@ MICS化学
@ YAMATO 
@ YA-MAN
@ NIX
@ EMCOM HOLDINGS
@ 3-D Matrix
@ chuo kagaku co.
@ THE SAILOR PEN
@ EIDAI KAKO
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Nissan Motor
graph
NITCHITSU 
graph
PIONEER etc.
graph
SANKEI CHEMICAL
graph
Nittetsu Mining
graph

Credit Rating Analysis: THE SAILOR PEN (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): THE SAILOR PEN (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2012-12-31  C  Credit is extremely vulnerable. The lowest rating. ¥ 6 B
-2.30%
¥ -26 M
96.26%
¥ -126 M
83.17%

Financial Timeline

Date  2012-12-31 
(Annual )
 2013-03-31 
(First quarter )
 2013-06-30 
(Second quarter )
 2013-09-30 
(Third quarter )
Credit Rating CCCC
Total Assets
¥ 6 B
¥ 6 B
¥ 6 B
¥ 6 B
Net Assets
¥ 428 M
¥ 434 M
¥ 449 M
¥ 474 M

Financial Statement Risk Analysis: THE SAILOR PEN (Annual ) (Consolidated )

Special note
Net income is minus 4 consecutive terms. The business have very high risk.
The change of Operating cash flow is going too far. The management situation is unstable.
4 consecutive terms, Cumulative loss. The fiscal base is unstable.
Net Assets have dropped 4 consecutive terms. The fiscal base is getting worse.
[Date: 2012-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -1 B) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -126 M) is minus or 0, so , there is a possibility that the management situation is severe.
Management Risk (*Sales is decrease )
Sales (¥ 6 B) is first term Sales (¥ 6 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Gross Income is decrease )
Gross Income (¥ 4 B) is first term Gross Income (¥ 5 B) less , there is a possibility that the management situation has stagnated and deteriorated
Non-performing asset Risk
Net Income (¥ -126 M) is a minus, Other Current Assets (¥ 2 B) - more than 50% of Total Assets (¥ 4 B) is occupied , there is a possibility of holding the non-performing asset.
[Date: 2011-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -1 B) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -749 M) & Operating Cash Flow (¥ -346 M) is minus or 0, so , there is a possibility that the management situation is very severe.
Management Risk (*Sales is decrease )
Sales (¥ 6 B) is first term Sales (¥ 6 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -346 M) is a minus, Financial Cash Flow (¥ 86 M) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.
Non-performing asset Risk
Net Income (¥ -749 M) Operating Cash Flow (¥ -346 M) is a minus, Other Current Assets (¥ 2 B) - more than 50% of Total Assets (¥ 4 B) is occupied , there is a possibility of holding the non-performing asset.
Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -346 M) and Investment Cash Flow (¥ -4 M) is minus, so , there is a possibility of the overinvestment.
[Date: 2010-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -1 B) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -1 B) & Operating Cash Flow (¥ -185 M) is minus or 0, so , there is a possibility that the management situation is very severe.
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -294 M) is a minus, Issuance of new shares (¥ 151 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ -553 M) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-16.13%) is first term Net Profit Margin (-8.38%) less , there is a possibility that the profitability has deteriorated.
Financing Risk (*Operating Cash Flow is minus or 0 &Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ -553 M) less, however Operating Cash Flow (¥ -185 M) is compensated for Investment Cash Flow (¥ 363 M) etc. , there is a possibility that the financing is severe.
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 363 M) is a plus, Issuance of new shares (¥ 151 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.
Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 6 B) is first term (¥ 6 B) more, however Operating Cash Flow (¥ -185 M) is first term (¥ 66 M) less , there is a possibility that the financing has deteriorated very much.
Financing Risk (*Sale of stock property)
Operating Cash Flow (¥ -185 M) is minus, Investment Cash Flow (¥ 363 M) is plus. Because the main occupation was dull, stock property may have been sold off.
Non-performing asset Risk
Net Income (¥ -1 B) Operating Cash Flow (¥ -185 M) is a minus, Other Current Assets (¥ 3 B) - more than 50% of Total Assets (¥ 5 B) is occupied , there is a possibility of holding the non-performing asset.
[Date: 2009-12-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -230 M) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -395 M) is a minus, Issuance of new shares (¥ 190 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -553 M) is minus or 0, so , there is a possibility that the management situation is severe.
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 382 M) is a plus, Issuance of new shares (¥ 190 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.

Ticker Market Industry Month report Rating
@ THE SAILOR PEN 7992 TSE 2st Other Products 12 Annual C

Related Company

@ MICS化学 (Sales ¥ 2 B)
@ EMCOM HOLDINGS (Sales ¥ 2 B)
@ マルマン (Sales ¥ 6 B)
@ chuo kagaku co. (Sales ¥ 59 B)
@ UMN Pharma (Sales ¥ 108 M)
@ NIPPON ICHI SOFTWARE (Sales ¥ 2 B)
@ Kurogane Kosakusho (Sales ¥ 10 B)
@ THE SAILOR PEN (Sales ¥ 6 B)
@ Medrx (Sales ¥ 87 M)
@ NIX (Sales ¥ 3 B)
@ YAMATO  (Sales ¥ 124 M)
@ EIDAI KAKO (Sales ¥ 5 B)
@ FUJICOPIAN (Sales ¥ 9 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.077 sec.)